Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Intercostal Nerve Block for Chronic Post-thoracotomy Pain
Unknown statusNot applicableNCT05556122
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The patients were divided into two groups by random number method: GroupRD1 group and GroupRD2 group were given general anesthesia and intercostal nerve block.The drug for intercostal nerve block was 0.33% ropivacaine +2.333mg compound betamethasone (1.667mg betamethasone dipropionate + 0.667mg betamethasone sodium phosphate) to 15ml.
Study details
- Official title
- Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Slit Intercostals Nerve Block for Chronic Post-thoracotomy Pain:A Single Blind Randomized Control Trial
- Conditions
- Nerve Block
- Interventions
- Other: intercostal nerve block
- Other: lateral intercostal nerve block
- Drug: ropivacaine + compound betamethasone
- Sponsor
- Affiliated Hospital of Nantong University
- Start date
- 2022-07-04
- Primary completion
- 2022-12-30
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. 18-70 years old 2. ASA grade I-III 3. BMI: 18.5-28kg/m2 4. Type of surgery: elective thoracoscopic lung mass resection 5. Informed consent has been signed by the patient and/or family members Exclusion Criteria: 1. game anesthesia or sugar cortical hormone drugs allergic 2. preoperative use of opioid medicines 3. serious blood coagulation dysfunction 4. serious heart, lung, liver and renal insufficiency 5. put, chemotherapy, and glucocorticoid immunosuppressive therapy history or diseases of the immune system 6. peptic ulcer 7. newly gastrointestinal surgery 8. has a history of thoracic surgery 9. is the central nervous system disease 10. Other glucocorticoids should be used with caution in patients such as fractures, wound repair, corneal ulcers, hyperadrenocortical disease, diabetes mellitus, pregnant women, etc.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05556122